Proteon logo     Print Page | Close Window

SEC Filings

S-1
PROTEON THERAPEUTICS INC filed this Form S-1 on 09/16/2014
Entire Document
 

Table of Contents

common stock. Each $1.00 decrease in the assumed initial public offering price (until the assumed initial public offering price is equal to $            ) would decrease by an additional             shares the number of shares of our common stock that would be issued upon the conversion of our Series D convertible preferred stock at the closing of this offering. In the event of a decrease in the assumed initial public offering price to a price that is equal to or less than $            , the            shares of our Series D convertible preferred stock outstanding as of                        , 2014 automatically will convert into            shares of our common stock upon the closing of this offering. Each $1.00 increase in the assumed initial public offering price above $            would increase by an additional            shares the number of shares of our common stock that would be issued upon the conversion of our Series D convertible preferred stock at the closing of this offering. In the event that the assumed initial public offering price is greater than $            , each decrease of            shares in the number of shares purchased in this offering by holders of our Series D convertible preferred stock would decrease by an additional            shares the number of shares of our common stock that would be issued upon the conversion of our Series D convertible preferred stock at the closing of this offering.

        The following number of shares of common stock would be outstanding upon the conversion of our Series D convertible preferred stock, assuming the initial public offering prices for our common stock shown below:

 
  Assumed Initial Public Offering Price  
 
  $  .00   $  .00   $  .00   $  .00   $  .00  

Shares Outstanding

                                                                           

60